Contact us
Anti-Inflammatory Research Explore how the peptide mix reduces inflammation in various models Muscle Recovery Studies Examine the combined influence on muscle repair and recovery processes Active Ingredients: BPC-157 5 mg TB-500 5 mg Inactive Ingredients: Lyophilized powder without preservatives Peptide Mix Vials: Quantity based on selected package Antibacterial Water: Equal number of 2 ml vials for reconstitution Test Certificate: Included for purity confirmation BPC-157 & TB-500 Mix 5 out of 5 based on 1 customer rating EUR 64.44 EUR 64.44 EUR 64.44 sample BP-TB is a dual-peptide research blend combining two well-studied compounds at 5 mg each per vial, supplied as a lyophilized powder
Every patient receives a personalized treatment plan with medical oversight
Poster Session II - RISK FACTORS - PRIMARY AND SECONDAR PREVENTION 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.03 - EPIDEMIOLOGY & RISK FACTORS P1017 - ESOC25-519 VAGOTOMY AND RISK OF STROKE COMPARED WITH MATCHED GENERAL POPULATION: A POPULATION-BASED COHORT STUDY Oscar Rosenkrantz 1 , Pter Szentkti 1 , Nils Skajaa 2 , Dvid Nagy 1 , Erzsbet Horvth-Puh 1 , Holly Elser 1,3,4 , Cecilia Hvitfeldt Fuglsang 1 , Henrik Toft Srensen 1 1 Department of Clinical Epidemiology, Aarhus University Hospital and Aarhus University, Aarhus, Denmark, 2 Novo Nordisk A/S, Sborg, Denmark, 3 Department of Neurology, University of Pennsylvania, Philadelphia, United States, 4 Center for Population Health Sciences, Stanford University, Palo Alto, United States Background and Aims: Vagotomy, used to treat refractory peptic ulcers decades ago, has been associated with reduced risk of selected neurological diseases, possibly by disrupting axonal transport of microbial organisms or misfolded proteins via the vagus nerve to the brain
At Trusta Clinic, we supply pharmaceutical-grade BPC-157 exclusively as part of a supervised clinical protocol
